Modulation with cytokines of radiation injury: Suggested mechanisms of action

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 6, 1997, Pages 1463-1465

  Neta, Ruth ^a  

^a U S DEPARTMENT OF ENERGY   (United States)

Author keywords

Cytokines; Interleukin 1; Radiation; Radiation injury; Radioprotection; Stem cell factor; Tumor growth factor beta; Tumor necrosis factor

Indexed keywords

CANCER GROWTH FACTOR; CYTOKINE; CYTOKINE ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 12; SCAVENGER; STEM CELL FACTOR; TUMOR NECROSIS FACTOR;

AEROBIC METABOLISM; APOPTOSIS; CLINICAL RESEARCH; CONFERENCE PAPER; CYTOCHEMISTRY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DRUG MECHANISM; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; IONIZING RADIATION; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RADIOSENSITIZATION; STEM CELL;

EID: 0031459747     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s61463     Document Type: Conference Paper

References (16)

1. Smith WW, Alderman IM, Gillespie RI. Increased survival in irradiated animals treated with bacterial endotoxins. Am J Physiol 191:124-131 (1957).
2. Neta R, Douches SD, Oppenheim JJ. Interleukin-1 is a radioprotector. J Immunol 136:2483-2485 (1986).
3. Neta R, Sayers T, Oppenheim JJ. Relationship of tumor necrosis factor to interleukins. In: Tumor Necrosis Factor: Structure, Function and Mechanism of Action (Vilcek J, Aggarwal B, eds). New York:Marcel Dekker, 1991;499-566.
4. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Nature 274:782-784 (1996).
5. Miller LL, Neta R. Therapeutic utility of cytokines in counter-acting the bone marrow suppression of radio- and chemo-therapy. In: Clinical Applications of Cytokines: Role in Pathogenesis, Diagnosis and Therapy (Gearing A, Rossio J, Oppenheim JJ, eds). New York:Oxford University Press, 1993;225-236.
6. Neta R, Oppenheim JJ. Radioprotection with cytokines. Learning from nature to cope with radiation damage. Cancer Cell 3:391-396 (1991).
7. Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, MacVittie TJ. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor β) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med 173:1177-1182 (1991).
8. Neta R, Oppenheim JJ, Wang JM, Snapper CM, Moorman MA, Dubois CM. Synergy of IL-1 and c-kit ligand (KL) in radioprotection of mice correlates with IL-1 upregulation of mRNA and protein expression for c-kit on bone marrow cells. J Immunol 153:1536-1543 (1994).
9. Neta R, Oppenheim JJ, Douches SD. Interdependence of the radioprotective effects of human recombinant IL-1, TNF, G-CSF, and murine recombinant G-CSF. J Immunol 140:108-111 (1988).
10. Neta R, Okunieff P. Cytokine-induced radiation protection and sensitization. Seminars Radiat Oncol 6:306-320 (1996).
11. Neta R, Oppenheim JJ. IL-1: can we exploit Jekyll and subjugate Hyde? In: Biologic Therapy of Cancer Updates, Vol 2 (10) (DeVita V, Rosenberg S, eds). New York:Lippincott, 1992;1-11.
12. Neta R, Keller JK, Ali N, Dubois CM. Contrasting mechanisms of myeloprotective effects of IL-1 against ionizing radiation and cytoablative 5-fluorouracil (5-FU). Radiat Res 145:624-631 (1996).
13. Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol 49:357-380 (1986).
14. Aleksandrow MG, Moses HL. Transforming growth factor β and cell cycle regulation. Cancer Res 55:1452-1457 (1995).
15. Trincheri G. Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Ann Rev Immunol 13:251-276 (1995).
16. Neta R, Stiefel SM, Finkelman F, Herrmann S, Ali N. Interleukin-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. J Immunol 153:4230-4237 (1994).